Aurobindo Pharma USA is voluntarily recalling a lot of their Gabapentin Capsules, because some of them contain some empty capsules, according to the FDA website.
The affected Gabapentin lot is GESB14011-A, Expiration 12/2015 and is packaged in 100-count bottles, NDC 16714-662-01. The product can be identified by the imprint D on yellow cap and 03 on yellow body with black edible ink.
It was distributed through Northstar label to retail outlets nationwide.
New Jersey-based Aurobindo Pharma USA has not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules.
Gabapentin is used as in the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles), and empty capsules could result in missed dose(s) of gabapentin resulting in adverse health consequences that could range from no effect, short term reduction in efficacy, short term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening.
